• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用深度学习方法预测三阴性乳腺癌(TNBC)患者的复发情况。

Predicting Relapse in Patients With Triple Negative Breast Cancer (TNBC) Using a Deep-Learning Approach.

作者信息

Yu Guangyuan, Li Xuefei, He Ting-Fang, Gruosso Tina, Zuo Dongmei, Souleimanova Margarita, Ramos Valentina Muñoz, Omeroglu Atilla, Meterissian Sarkis, Guiot Marie-Christine, Yang Li, Yuan Yuan, Park Morag, Lee Peter P, Levine Herbert

机构信息

Department of Physics and Astronomy, Rice University, Houston, TX, United States.

Center for Theoretical Biological Physics, Rice University, Houston, TX, United States.

出版信息

Front Physiol. 2020 Sep 23;11:511071. doi: 10.3389/fphys.2020.511071. eCollection 2020.

DOI:10.3389/fphys.2020.511071
PMID:33071806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7538858/
Abstract

The abundance and/or location of tumor infiltrating lymphocytes (TILs), especially CD8 T cells, in solid tumors can serve as a prognostic indicator in various types of cancer. However, it is often difficult to select an appropriate threshold value in order to stratify patients into well-defined risk groups. It is also important to select appropriate tumor regions to quantify the abundance of TILs. On the other hand, machine-learning approaches can stratify patients in an unbiased and automatic fashion. Based on immunofluorescence (IF) images of CD8 T lymphocytes and cancer cells, we develop a machine-learning approach which can predict the risk of relapse for patients with Triple Negative Breast Cancer (TNBC). Tumor-section images from 9 patients with poor outcome and 15 patients with good outcome were used as a training set. Tumor-section images of 29 patients in an independent cohort were used to test the predictive power of our algorithm. In the test cohort, 6 (out of 29) patients who belong to the poor-outcome group were all correctly identified by our algorithm; for the 23 (out of 29) patients who belong to the good-outcome group, 17 were correctly predicted with some evidence that improvement is possible if other measures, such as the grade of tumors, are factored in. Our approach does not involve arbitrarily defined metrics and can be applied to other types of cancer in which the abundance/location of CD8 T lymphocytes/other types of cells is an indicator of prognosis.

摘要

实体瘤中肿瘤浸润淋巴细胞(TILs),尤其是CD8 T细胞的数量和/或位置,可作为多种癌症的预后指标。然而,为了将患者分层到明确的风险组中,通常很难选择合适的阈值。选择合适的肿瘤区域来量化TILs的数量也很重要。另一方面,机器学习方法可以以无偏且自动的方式对患者进行分层。基于CD8 T淋巴细胞和癌细胞的免疫荧光(IF)图像,我们开发了一种机器学习方法,该方法可以预测三阴性乳腺癌(TNBC)患者的复发风险。来自9例预后不良患者和15例预后良好患者的肿瘤切片图像用作训练集。独立队列中29例患者的肿瘤切片图像用于测试我们算法的预测能力。在测试队列中,我们的算法正确识别出了29例中属于预后不良组的6例患者;对于29例中属于预后良好组的23例患者,正确预测了17例,并且有证据表明,如果考虑其他因素,如肿瘤分级,预测可能会有所改善。我们的方法不涉及任意定义的指标,可应用于CD8 T淋巴细胞/其他类型细胞的数量/位置是预后指标的其他类型癌症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/eb1f7e6bbd71/fphys-11-511071-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/fb94d13c231c/fphys-11-511071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/6096f2cc71b2/fphys-11-511071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/b86377f373c0/fphys-11-511071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/eb1f7e6bbd71/fphys-11-511071-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/fb94d13c231c/fphys-11-511071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/6096f2cc71b2/fphys-11-511071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/b86377f373c0/fphys-11-511071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57b/7538858/eb1f7e6bbd71/fphys-11-511071-g004.jpg

相似文献

1
Predicting Relapse in Patients With Triple Negative Breast Cancer (TNBC) Using a Deep-Learning Approach.使用深度学习方法预测三阴性乳腺癌(TNBC)患者的复发情况。
Front Physiol. 2020 Sep 23;11:511071. doi: 10.3389/fphys.2020.511071. eCollection 2020.
2
The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.肿瘤-宿主界面处肿瘤浸润淋巴细胞的CD4/CD8比值在三阴性乳腺癌中具有预后价值。
Hum Pathol. 2017 Nov;69:110-117. doi: 10.1016/j.humpath.2017.09.012. Epub 2017 Oct 6.
3
Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.肿瘤浸润淋巴细胞及拓扑异构酶IIα表达在紫杉烷-蒽环类新辅助化疗后三阴性乳腺癌患者临床结局预测中的意义
Chemotherapy. 2017;62(4):246-255. doi: 10.1159/000470900. Epub 2017 May 5.
4
Tumor-infiltrating lymphocytes and CD8 T cells predict survival of triple-negative breast cancer.肿瘤浸润淋巴细胞和 CD8 T 细胞预测三阴性乳腺癌的生存。
J Cancer Res Clin Oncol. 2019 Dec;145(12):3105-3114. doi: 10.1007/s00432-019-03036-5. Epub 2019 Sep 27.
5
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.MxA表达与肿瘤浸润淋巴细胞相关,是三阴性乳腺癌的一个预后因素。
Breast Cancer Res Treat. 2016 Apr;156(3):597-606. doi: 10.1007/s10549-016-3786-z. Epub 2016 Apr 13.
6
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.三阴性乳腺癌新辅助化疗后残留肿瘤中肿瘤浸润性CD8 +和FOXP3 +淋巴细胞的预后意义及这些参数的变化:一项回顾性多中心研究
Breast Cancer Res. 2015 Sep 4;17(1):124. doi: 10.1186/s13058-015-0632-x.
7
T-bet lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.T 细胞浸润作为三阴性乳腺癌的一个独立预后良好的指标。
Breast Cancer Res Treat. 2019 Aug;176(3):569-577. doi: 10.1007/s10549-019-05256-2. Epub 2019 May 8.
8
Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.联合评估FAS细胞表面死亡受体和CD8 +肿瘤浸润淋巴细胞作为乳腺癌的预后生物标志物
Oncotarget. 2017 Feb 28;8(9):15610-15620. doi: 10.18632/oncotarget.14779.
9
Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer.新辅助治疗前后三阴性和 HER2 阳性乳腺癌中基质肿瘤浸润淋巴细胞的预测和预后价值。
Eur J Cancer. 2019 Sep;118:41-48. doi: 10.1016/j.ejca.2019.05.014. Epub 2019 Jul 11.
10
The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer.Foxp3+/CD25+ 调节性 T 细胞和 PD-L1 表达在三阴性乳腺癌中的预测和预后价值。
Ann Diagn Pathol. 2019 Jun;40:143-151. doi: 10.1016/j.anndiagpath.2019.04.004. Epub 2019 Apr 10.

引用本文的文献

1
Deep learning for survival prediction in triple-negative breast cancer: development and validation in real-world cohorts.深度学习用于三阴性乳腺癌的生存预测:在真实世界队列中的开发与验证
Sci Rep. 2025 Aug 18;15(1):30248. doi: 10.1038/s41598-025-16331-8.
2
Artificial Intelligence for Precision Oncology of Triple-Negative Breast Cancer: Learning from Melanoma.用于三阴性乳腺癌精准肿瘤学的人工智能:从黑色素瘤中汲取经验。
Cancers (Basel). 2024 Feb 6;16(4):692. doi: 10.3390/cancers16040692.
3
A Review of AI-Based Radiomics and Computational Pathology Approaches in Triple-Negative Breast Cancer: Current Applications and Perspectives.

本文引用的文献

1
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers.空间上不同的肿瘤免疫微环境将三阴性乳腺癌分层。
J Clin Invest. 2019 Apr 1;129(4):1785-1800. doi: 10.1172/JCI96313. Epub 2019 Mar 18.
2
Infiltration of CD8 T cells into tumor cell clusters in triple-negative breast cancer.浸润性 CD8 T 细胞进入三阴性乳腺癌的肿瘤细胞簇。
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3678-3687. doi: 10.1073/pnas.1817652116. Epub 2019 Feb 7.
3
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
基于人工智能的放射组学和计算病理学在三阴性乳腺癌中的研究进展:当前的应用与展望。
Clin Breast Cancer. 2023 Dec;23(8):800-812. doi: 10.1016/j.clbc.2023.06.004. Epub 2023 Jun 21.
4
The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial-Mesenchymal Transition.三阴性乳腺癌对新辅助化疗的反应和上皮-间充质转化。
Int J Mol Sci. 2023 Mar 29;24(7):6422. doi: 10.3390/ijms24076422.
5
A pathomic approach for tumor-infiltrating lymphocytes classification on breast cancer digital pathology images.一种用于乳腺癌数字病理图像中肿瘤浸润淋巴细胞分类的病理方法。
Heliyon. 2023 Mar 9;9(3):e14371. doi: 10.1016/j.heliyon.2023.e14371. eCollection 2023 Mar.
6
Quantitative Assessment of Tumor-Infiltrating Lymphocytes Using Machine Learning Predicts Survival in Muscle-Invasive Bladder Cancer.使用机器学习对肿瘤浸润淋巴细胞进行定量评估可预测肌层浸润性膀胱癌的生存期。
J Clin Med. 2022 Nov 29;11(23):7081. doi: 10.3390/jcm11237081.
7
Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment.通过上皮间质转化和肿瘤免疫微环境对三阴性乳腺癌进行分类。
Sci Rep. 2022 Jun 10;12(1):9651. doi: 10.1038/s41598-022-13428-2.
单细胞测序对非小细胞肺癌 T 细胞的全面刻画。
Nat Med. 2018 Jul;24(7):978-985. doi: 10.1038/s41591-018-0045-3. Epub 2018 Jun 25.
4
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images.利用病理学图像上的深度学习技术研究肿瘤浸润淋巴细胞的空间组织和分子相关性。
Cell Rep. 2018 Apr 3;23(1):181-193.e7. doi: 10.1016/j.celrep.2018.03.086.
5
Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis.N-钙黏蛋白表达上调与上皮源性实体瘤不良预后相关:一项荟萃分析。
Eur J Clin Invest. 2018 Apr;48(4). doi: 10.1111/eci.12903. Epub 2018 Feb 25.
6
Prediction of breast cancer risk using a machine learning approach embedded with a locality preserving projection algorithm.基于局部保持投影算法的机器学习方法预测乳腺癌风险。
Phys Med Biol. 2018 Jan 30;63(3):035020. doi: 10.1088/1361-6560/aaa1ca.
7
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer.肿瘤内 T 细胞的空间计算与胰腺癌患者的生存相关。
Nat Commun. 2017 Apr 27;8:15095. doi: 10.1038/ncomms15095.
8
Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.非小细胞肺癌中的上皮-间质转化
Anticancer Res. 2017 Apr;37(4):1773-1778. doi: 10.21873/anticanres.11510.
9
Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015.癌症中的免疫评分与免疫剖析:来自2015年黑色素瘤与免疫治疗桥梁会议的最新进展
J Transl Med. 2016 Sep 20;14:273. doi: 10.1186/s12967-016-1029-z.
10
How Do Cytotoxic Lymphocytes Kill Cancer Cells?细胞毒性淋巴细胞如何杀死癌细胞?
Clin Cancer Res. 2015 Nov 15;21(22):5047-56. doi: 10.1158/1078-0432.CCR-15-0685.